Evidence map›Paper›PMID 36835976›Full record

ArticleJournal of clinical medicine2023

Data Resource Profile: The Multiple Sclerosis Documentation System 3D and AOK PLUS Linked Database (MSDS-AOK PLUS).

Marco Ghiani, Evi Zhuleku, Anja Dillenseger, Ulf Maywald, Andreas Fuchs, Thomas Wilke, Tjalf Ziemssen

Abstract read
In one paragraph

Article in Journal of clinical medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Marco GhianiInstitut für Pharmakoökonomie und Arzneimittellogistik e.V. (IPAM e.V.), 23966 Wismar, Germany.
Evi ZhulekuCytel Inc., 10785 Berlin, Germany.
Anja DillensegerZKN, Zentrum für Klinische Neurowissenschaften, Neurologische Klinik und Poliklinik für Neurologie, Universitätsklinikum Carl Gustav Carus, 01307 Dresden, Germany.
Ulf MaywaldAOK PLUS, 01067 Dresden, Germany.
Andreas FuchsAOK PLUS, 01067 Dresden, Germany.
Thomas WilkeInstitut für Pharmakoökonomie und Arzneimittellogistik e.V. (IPAM e.V.), 23966 Wismar, Germany.
Tjalf ZiemssenZKN, Zentrum für Klinische Neurowissenschaften, Neurologische Klinik und Poliklinik für Neurologie, Universitätsklinikum Carl Gustav Carus, 01307 Dresden, Germany.ORCID 0000-0001-8799-8202

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Real-world evidence in multiple sclerosis (MS) is limited by the availability of data elements in individual real-world datasets. We introduce a novel, growing database which links administrative claims and medical records from an MS patient management system, allowing for the complete capture of patient profiles. Using the AOK PLUS sickness fund and the Multiple Sclerosis Documentation System MSDS

Indexed as

administrative claimselectronic medical recordslinked databasemultiple sclerosisreal-world evidence

Identifiers

PMID36835976
PMCPMC9962623

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.